elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34512818-531F4E35-4DED-4718-B773-352FD66CD020
Q34512818-531F4E35-4DED-4718-B773-352FD66CD020
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34512818-531F4E35-4DED-4718-B773-352FD66CD020
Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticity.
P2860
Q34512818-531F4E35-4DED-4718-B773-352FD66CD020
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34512818-531F4E35-4DED-4718-B773-352FD66CD020
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
240f0ee311fab00d988635308ac1c3357d794358
P2860
GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects.